BioSpace News Archive

Quidel Corporation has been honored with three awards for creative excellence from the international MarCom Awards competition, just announced. Quidel is the diagnostic health care manufacturer behind the industry’s most rapid and reliable in-office test for Lyme disease, the Sofia® 2 Lyme FIA test. The MarCom Awards is an international creative competition that recognizes outstanding achievement by marketing and commun

NightWare, a medical device company focused on treating people with nightmares related to post-traumatic stress disorder (PTSD) and other traumatic events, has announced it has received U.S. Food and Drug Administration (FDA) marketing permission for the NightWare™ therapeutic platform. NightWare is the first and only medical device to be indicated for the temporary reduction of sleep disturbance related to nightmares in adu

In partnership with renowned imaging research center, Neuro42 to commercialize technology that helps physicians triage patients with neurological diseases and injuries sooner

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwright 6 th Annual Israel Conference on November 12 th , 2020. H.C. Wainwright 6th Annual Israel Conference – Thursday November 12, 2020 Presentation Time : 3:30pm Weblink : https://journey.ct.events

Today Atlantic Therapeutics announces that Heidi Zak , co-founder and CEO of ThirdLove will take on an advisory role in the acceleration of the INNOVO ® brand. INNOVO ® is a direct-to-consumer, FDA-approved medical device offering a clinically proven solution to stress urinary incontinence (SUI). INNOVO ® is poised to disrupt the huge

Precision® Extraction Solutions (“Precision”), the world leader in cannabis and hemp extraction technology, today released the new, state-of-the-art XMU extractor that is the most powerful extraction platform on the market

I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved diagnostic and analyzing tool that performs 9 exams in under 10 minutes.

Laurel Bridge Software, a provider of software solutions that enable healthcare organizations to orchestrate their medical imaging workflows, recently released a new white paper entitled “Medical Imaging AI - Why Robust and Adaptable Workflow is Required to Realize its Clinical Value”

NEO is excited to announce that Cybin Inc., a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, has made its debut on the global public markets

Researchers at the Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – discovered that a small cluster of neurons within the brain is responsible for controlling the body’s immune response and the release of cytokines, which leads to inflammation in the body.